The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Open accessAbstract
Background and aim: Abdominal pain and discomfort are common symptoms in functional disorders and are attributed to visceral hypersensitivity. These symptoms fluctuate over time but the basis for this is unknown. Here we examine the impact of changes in gut flora and gut inflammatory cell activity on visceral sensitivity. Methods: Visceral sensitivity to colorectal distension (CRD) was assessed at intervals in healthy mice for up to 12 weeks, and in mice before and after administration of dexamethasone or non-absorbable antibiotics with or without supplementation with Lactobacillus paracasei (NCC2461). Tissue was obtained for measurement of myeloperoxidase activity (MPO), histology, microbiota analysis, and substance P (SP) immunolabelling. Results: Visceral hypersensitivity developed over time in healthy mice maintained without sterile precautions. This was accompanied by a small increase in MPO activity. Dexamethasone treatment normalised MPO and CRD responses. Antibiotic treatment perturbed gut flora, increased MPO and SP immunoreactivity in the colon, and produced visceral hypersensitivity. Administration of Lactobacillus paracasei in spent culture medium normalised visceral sensitivity and SP immunolabelling, but not intestinal microbiota counts. Conclusion: Perturbations in gut flora and in inflammatory cell activity alter sensory neurotransmitter content in the colon, and result in altered visceral perception. Changes in gut flora may be a basis for the variability of abdominal symptoms observed in functional gastrointestinal disorders and may be prevented by specific probiotic administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [59]
In the citing paper
“In mice, perturbation of the microbiota by exposure to antibiotics resulted in increased visceromotor responses to colonic distension (182).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [182]
In the citing paper
“Interestingly, in this model, treatment of mice with Lactobacillus ameliorated inflammatory indexes in the gut wall and reduced the antibiotic-induced visceromotor response.”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [182]
In the citing paper
“Moreover, several studies linking the gut microbiota with visceral sensitivity, have shown that increments in the Lactobacilli family (during probiotic treatment or during states of dysbiosis) are associated to visceral analgesic-like states.18,19,21,33”
From Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Interactions between commensal intestinal bacteria and the immune system
Macpherson, A. J., & Harris, N. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1373 · Cited by 1,683
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Nobaek, S., Johansson, M.-L., Molin, G., Ahrné, S., & Jeppsson, B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02015.x · Cited by 653
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial
Atkinson, W., Sheldon, T. A., Shaath, N., & Whorwell, P. J. (2004) · Gut · doi:10.1136/gut.2003.037697 · Cited by 534
Abnormal colonic fermentation in irritable bowel syndrome
King, T. S., Elia, M., & Hunter, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02146-1 · Cited by 473
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- 2003, Rev Gastroenterol Disord, S12, 12
- 1998, Dev Immunol, 6, 13
- 1968, Lab Anim Care, 18, 1
- 2004, J Orofac Pain, 18, 62
- 2004, Gastroenterology, 126, A161
- 1968, Am J Med Sci, 255, 63
- 2003, Folia Morphol (Warsz), 62, 455
- 1999, Am J Physiol, 277, L831
- 10.1046/j.1365-2982.2003.00458.x · DOI
Cited by
Sorted by citations
Items 401–448 of 448
Collins, S., Bercik, P., Denou, E., & Verdú, E. (2010) · Bioscience and Microflora · doi:10.12938/bifidus.29.179
Self-citation[Irritable bowel syndrome: a functional disorder?].
Man, F., & Fernández, L. M. B. (2013) · PubMed
Neuroimmunomodulation, Stress–Nutrition Interactions and Diet
Marín, J. R., Wärnberǵ, J., Nova, E., Gómez-Martínez, S., Díaz, L. E., Veses, A. M., & Marcos, A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-061-8_5
The benefits of probiotics in irritable bowel syndrome
Emmanuel, A. V. (2013) · Gastrointestinal Nursing · doi:10.12968/gasn.2013.11.4.21
Staudacher, H. M., Lomer, M. C. E., Anderson, J. E., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012)
Inflammation, Microflora, Motility, and Visceral Sensitivity
Michail, S. K., & Ng, M.-W. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-709-9_5
Microbiote et intestin irritable
Duboc, H. (2014) · Côlon & Rectum · doi:10.1007/s11725-014-0539-1
Potentials of Probiotics as Alternative Therapy in Combating Bacterial Diseases: A Review
Salisu, S. (2014) · British Journal of Applied Science & Technology · doi:10.9734/bjast/2014/6577
Microbiote urinaire et troubles mictionnels
Amarenco, G. (2015) · The French Journal of Urology · doi:10.1016/j.purol.2015.04.007
Dietary Interventions and Irritable Bowel Syndrome
Thomas, A., & Quigley, E. M. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00020-7
The Future of Prebiotics and Probiotics
Brunser, O., Bravo, J., & Gotteland, M. (2013) · CRC Press eBooks · doi:10.1201/b15561-24
Thijssen, A. Y. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151119at
Cognitive and hedonic responses to meal ingestion
Pribić, T. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Prospects for using probiotics in the treatment of constipation in children
Zakharova, I. N., Osmanov, I. M., Berezhnaya, I. V., Анатольевич, К. К., Dedikova, O. V., Kuchina, A. E., & Sazanova, Y. О. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-11-85-90
Early Life Exposure to Antibiotics and Mood and Anxiety Disorders in Children and Adolescents
Delara, M. (2019) · Mspace (University of Manitoba)
Geary, C. G., Wilk, V. C., Barton, K. L., Jefferson, P. O., Binder, T., Bhutani, V., Baker, C. L., Fernando‐Peiris, A. J., Mousley, A., Rozental, S. F. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.21.213116
Nutritional Therapies for Irritable Bowel Syndrome: a Focus on Prebiotics and Probiotics
Zoll, B. E., & Ahuja, N. K. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00320-z · Cited by 1
Modèles expérimentaux de douleurs pelvi-périnéales
Matricon, J., Gelot, A., & Ardid, D. (2007) · Douleur et Analgésie · doi:10.1007/s11724-007-0055-2
Critical Inspection of the Gut–Brain–Skin Triangle and Its Modulation Through Probiotics
Chugh, P., Sood, S., & Dhar, M. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_2
The benefits of probiotics in irritable bowel syndrome
Emmanuel, A. V. (2008) · Gastrointestinal Nursing · doi:10.12968/gasn.2008.6.3.29126
Wang, X., Wu, J., Qi, S., Huang, R., Wu, X., Tian, L., Wang, P., & Wang, S. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210604.15
Ali, M. (2020) · Annals of the Academy of Romanian Scientists Series on Biological Sciences · doi:10.56082/annalsarscibio.2020.2.50
Les lipides bactériens dans la douleur viscérale intestinale
Petitfils, C., & Cénac, N. (2022) · Douleur et Analgésie · doi:10.3166/dea-2022-0221
Fixing the Damage: The Evolution of Probiotics from Fermented Food to Biotherapeutic Products
de Freitas, P. N. N., Silva, C. R., Constantin, P. P., Pileggi, S. A. V., Vicari, M. R., & Pileggi, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-24942-6_12
Microbiome therapeutics in psychological disorders
Ortíz, G. G., Bitzer-Quintero, O. K., Ramírez-Jirano, L. J., Pacheco-Moisés, F. P., González-Usigli, H., Torres-Mendoza, B. M., Mireles-Ramírez, M. A., Torres-Sánchez, E. D., & Delgado-Lara, D. L. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00009-4
Ait-Belgnaoui, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Liu, X., & Wu, S. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i22.922
The Microbiome and Chronic Pain Syndromes
Charipova, K., Abd-Elsayed, A. A., & Gress, K. L. (2023) · Cambridge University Press eBooks · doi:10.1017/9781108979849.004
Verdu, E. F., & Vanner, S. J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2308956
Doğan, N. M., & Kart, N. N. B. (2024) · Journal of Turkish Sleep Medicine · doi:10.4274/jtsm.galenos.2023.97658
Role of Synbiotics in Inflammatory Lung Diseases
Ashique, S., Kumar, S., Upadhyay, A., Garg, A., Mishra, N., Kumar, P., Dua, K., Farid, A., & Hussain, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-5575-6_3 · Cited by 1
Sajjad, J., Morael, J., Melo, T. G., Foley, T., Murphy, A., Keane, J., Popov, J., Stanton, C., Dinan, T. G., Clarke, G. A., et al. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138096
Role of microbiota-gut-brain axis on neurotransmitter modulation
Anitha, K., Bhatt, S., Chikatipalli, R., & Ravula, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00016-x
Zhang, S., He, L., Zhang, L., Sun, J., Wang, Y., Wang, M., Zhao, Y., Sun, X., Yang, G., Li, Z., et al. (2025) · Updates in Surgery · doi:10.1007/s13304-025-02454-0
Physiopathologie du syndrome de l’intestin irritable (SII)
Jouet, P. (2013) · Côlon & Rectum · doi:10.1007/s11725-013-0456-8
The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression
Sangal, M. (2022) · Journal of High School Science · doi:10.64336/001c.56437
Immuno-Modulation Properties of Lactobacillus delbrueckii
Rocha, C. S. (2011) · theses.fr (ABES) · doi:10.70675/aec0ea62zd50dz47adzbbf9z3175e3e63a3e
Bally, P. (2015) · theses.fr (ABES) · doi:10.70675/bf447e7czf5dcz467bz88d6z8edaad84e76a · Cited by 2
Role du fructose dans la physiopathologie du syndrome de l'intestin irritable
Melchior, C. (2018) · theses.fr (ABES) · doi:10.70675/b07649edz908dz4d73za666z0112bc94cdf8
Kamphuis, J. B. J. (2019) · theses.fr (ABES) · doi:10.70675/e4003e6fzeffaz48a2z95a6zba874fe5eb4c
Mazenc, A. (2022) · theses.fr (ABES) · doi:10.70675/993fac83z1efdz4dd2z8639z1373d18cf659
Petitfils, C., & Cénac, N. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.0910
Tochitani, S., Yamamoto, Y., Saito, K., & Nagaoka, K. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106936
Gut health revolution: Probiotics and digestive wellness
Kunal, Gowda, A., Rajeshwari, G., Jogi, N., Mamatha, B. S., & Sharma, R. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45154-6.00028-3
Metadata
- Authors
- Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M.
- Affiliations
- McMaster University (CA)
- Nestlé (Switzerland) (CH)
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-08-16
- Volume
- 55
- Issue
- 2
- Pages
- 182-190
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1856497
- OpenAlex
- W2029071453
- Cited by
- 448
- References
- 47
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 19 · 2023: 20 · 2022: 21 · 2021: 25 · 2020: 32 · 2019: 23 · 2018: 23 · 2017: 25 · 2016: 26 · 2015: 27 · 2014: 27 · 2013: 26 · 2012: 26
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Gut (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Canadian Association of Gastroenterology
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- visceral hypersensitivity, probiotics, Lactobacillus paracasei, antibiotic-induced dysbiosis, gut microbiota, colorectal distension, dexamethasone, myeloperoxidase, substance P, gut-brain axis, functional gastrointestinal disorders, abdominal pain, intestinal inflammation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Anti-Bacterial Agents, Dexamethasone, Electromyography, Female, Hyperalgesia, Intestines, Mice, Inbred BALB C, Peroxidase, Physical Stimulation, Substance P, Abdominal Pain, Culture Media, Conditioned, Probiotics, Irritable Bowel Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
